AIM WINNERS & LOSERS: Gama Aviation eyes returns from Jet East sales
18th Oct 2023 10:47
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More
(Alliance News) - Ondine Biomedical Inc on Wednesday celebrated results from a new study showing that its Steriwave treatment dramatically reduced levels of antibiotic-resistant bacteria. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - Ondine Biomedical Inc on Friday said its Steriwave technology is now available in hospitals across Canada, with Nova Scotia's largest hospital becoming the latest facility to use it. Read More
(Alliance News) - Ondine Biomedical Inc on Monday reported its Steriwave nasal photodisinfection technology has been adopted by Penticton Regional Hospital in British Columbia, Canada, as a standard-of-care for patients undergoing orthopaedic surgery. Read More
(Alliance News) - Ondine Biomedical Inc on Monday said revenue rose by half as it narrowed its loss in the first half of the year. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc on Thursday said a new study has proven its Steriwave photodisinfection technology "highly effective" against drug-resistant pathogens on human tissues. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Partners with Kelowna General Hospital in Canada for a pilot program to prevent hospital-acquired infections using its Steriwave nasal photodisinfection therapy. Says Steriwave is already in use at a number of hospitals acrsoss Canada. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Says it has modified its Phase Three Clinical Trial Design for its lead product, Steriwave, to cover a broader range of hospital-acquired infections, including surgical site infections, bloodstream infections and pneumonias. The broadening of the design is not expected to have any impact on the recruitment rate into the trial. Read More
(Alliance News) - Ondine Biomedical Inc on Thursday said new data shows that its photodisinfection technology has "dramatically" reduced Covid-19 rates at a Canadian meat processing plant. Read More
(Alliance News) - Ondine Biomedical Inc on Wednesday reported a narrowed loss and was unfazed by an "anticipated" drop in revenue and increased expenses, and said it had "strong conviction" in its long-term prospects. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver-based life sciences company innovating in the field of photodisinfection therapies - Concludes the first development phase of a new food-safe photodisinfection technology from Canada's meat packing industry. Ondine's photodisinfection is a patented technology using a photosensitizer - a non-antibiotic, light-activated solution - to destroy pathogens. Read More
Ondine Biomedical Inc - Canadian life sciences company focused in the field of photodisinfection therapies - Steriwave, Ondine's nasal photodisinfection therapy, has been found to improve short- and long-term immune responses while also "significantly" reducing SARS-CoV-2 infectivity. This effect was detectable not only in antibody-mediated immunity, but also in T-cell mediated immunity. Read More